Related references
Note: Only part of the references are listed.Isolevuglandin-Type Lipid Aldehydes Induce the Inflammatory Response of Macrophages by Modifying Phosphatidylethanolamines and Activating the Receptor for Advanced Glycation Endproducts
Lilu Guo et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction
Sook Hee Ku et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
S100A12 and RAGE Expression in Human Bladder Transitional Cell Carcinoma: a Role for the Ligand/RAGE Axis in Tumor Progression?
Hossein Khorramdelazad et al.
Asian Pacific Journal of Cancer Prevention (2015)
Role of receptor for advanced glycation end products in the complication and progression of various types of cancers
Parth Malik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
Mohd W. Nasser et al.
CANCER RESEARCH (2015)
Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway
E. M. S. Litwinoff et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
Carmel M. McVicar et al.
DIABETOLOGIA (2015)
Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy
Eunsoo Jung et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure
Mohammad Dahrouj et al.
EXPERIMENTAL EYE RESEARCH (2015)
Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease
Douglas Walker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
A. Ojima et al.
HORMONE AND METABOLIC RESEARCH (2015)
Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma
Lingyin Zhu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
S100A8 is a Novel Therapeutic Target for Anaplastic Thyroid Carcinoma
Ashley N. Reeb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity?
Jaime Uribarri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Deletion of Receptor for Advanced Glycation End Products Exacerbates Lymphoproliferative Syndrome and Lupus Nephritis in B6-MRL Fas lpr/j Mice
Antoine Goury et al.
JOURNAL OF IMMUNOLOGY (2015)
Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice
Nicolas Grossin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells
Manoj Reddy Medapati et al.
THYROID (2015)
Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Ya-Hsuan Chang et al.
SCIENTIFIC REPORTS (2015)
Diabetic retinopathy - ocular complications of diabetes mellitus
Martin M. Nentwich et al.
WORLD JOURNAL OF DIABETES (2015)
Randomized Pilot Trial of Bariatric Surgery Versus Intensive Medical Weight Management on Diabetes Remission in Type 2 Diabetic Patients Who Do NOT Meet NIH Criteria for Surgery and the Role of Soluble RAGE as a Novel Biomarker of Success
Manish Parikh et al.
ANNALS OF SURGERY (2014)
Nε-(Carboxymethyl) lysine- Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance
Katrien H. J. Gaens et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Therapeutic targets for rheumatoid arthritis: Progress and promises
Abdullah Alghasham et al.
AUTOIMMUNITY (2014)
RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma
Xuebo Chen et al.
CANCER RESEARCH (2014)
Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?
Evangelos Marinakis et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
Christine Koulis et al.
CLINICAL SCIENCE (2014)
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
Fei Song et al.
DIABETES (2014)
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes
Greg Tesch et al.
DIABETOLOGIA (2014)
Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats
Qi Gu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway
Xu Wang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Claudio Franceschi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko et al.
NEUROLOGY (2014)
The Role of S100B in the Interaction Between Adipocytes and Macrophages
Atsushi Fujiya et al.
OBESITY (2014)
被撤回的出版物: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells (Retracted article. See vol. 15, 2020)
Minghua Yang et al.
PLOS ONE (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
Kei Fukami et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Robert Vassar
ALZHEIMERS RESEARCH & THERAPY (2014)
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease
Bo-Ryoung Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE-/- mice by downregulating the HMGB1-RAGE axis
Ming Liu et al.
ACTA PHARMACOLOGICA SINICA (2013)
Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease
Donavan T. Cheng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis
Rossana G. Iannitti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
RAGE in tissue homeostasis, repair and regeneration
Guglielmo Sorci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition
Chonggao Yin et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages
Huaqing Wang et al.
CLINICAL CANCER RESEARCH (2013)
RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice
Judyta K. Juranek et al.
DIABETES (2013)
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
Gurdip Daffu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells
Sergey Reverdatto et al.
PLOS ONE (2013)
Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth
Indira Elangovan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation
Emman Shubbar et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways
Mohd W. Nasser et al.
CANCER RESEARCH (2012)
Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways
Fatouma Toure et al.
CIRCULATION RESEARCH (2012)
Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
Eirini Christaki et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice
Anna M. D. Watson et al.
DIABETES (2012)
Opposing roles of RAGE and Myd88 signaling in extensive liver resection
Shan Zeng et al.
FASEB JOURNAL (2012)
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
Wei Yan et al.
HEPATOLOGY (2012)
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
Vivek Rai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
Vivek Rai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes
Ravichandran Ramasamy et al.
VASCULAR PHARMACOLOGY (2012)
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-κB
Marco Tafani et al.
CARCINOGENESIS (2011)
Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes An Analysis From the CARDS Trial
Helen M. Colhoun et al.
DIABETES (2011)
Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
Mei He et al.
EMBO REPORTS (2011)
High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products
Andrey Mazarati et al.
EXPERIMENTAL NEUROLOGY (2011)
S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release
Roberta Bianchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ROLE OF Aβ-RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS INTERACTION IN OXIDATIVE STRESS AND CYTOSOLIC PHOSPHOLIPASE A2 ACTIVATION IN ASTROCYTES AND CEREBRAL ENDOTHELIAL CELLS
S. Askarova et al.
NEUROSCIENCE (2011)
S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)
Qing'e Jin et al.
PLOS ONE (2011)
Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
Lasse Ramsgaard et al.
PLOS ONE (2011)
Advanced Glycation End Product Recognition by the Receptor for AGEs
Jing Xue et al.
STRUCTURE (2011)
Aldose Reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats
Kellie McCormick Hallam et al.
AGING CELL (2010)
Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation
Takanori Matsui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Formins in cell signaling
Kevin G. Young et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Activation of the ROCK1 Branch of the Transforming Growth Factor-β Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice
De-xiu Bu et al.
CIRCULATION RESEARCH (2010)
Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
Nina Reiniger et al.
DIABETES (2010)
Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE)
H. Zong et al.
DIABETOLOGIA (2010)
RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
Fang Fang et al.
FASEB JOURNAL (2010)
The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding
HaJeung Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages
Yunlu Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Association between the RAGE G82S polymorphism and Alzheimer's disease
Keshen Li et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis
Lasse Ramsgaard et al.
PLOS ONE (2010)
RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways
Linshan Shang et al.
PLOS ONE (2010)
Structural Basis for Ligand Recognition and Activation of RAGE
Michael Koch et al.
STRUCTURE (2010)
Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction
Jason D. Christie et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis
Hans L. A. Nienhuis et al.
AUTOIMMUNITY (2009)
RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice
Li Sun et al.
CARDIOVASCULAR RESEARCH (2009)
RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model
H. J. Cho et al.
FASEB JOURNAL (2009)
Soluble forms of RAGE in internal medicine
Natale Vazzana et al.
INTERNAL AND EMERGENCY MEDICINE (2009)
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
Helene Maillard-Lefebvre et al.
RHEUMATOLOGY (2009)
Atherosclerosis in autoimmune diseases
Eiji Matsuura et al.
Current Rheumatology Reports (2009)
Role of NADPH Oxidase in Retinal Microvascular Permeability Increase by RAGE Activation
Christina M. Warboys et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice
Susanne Bro et al.
ATHEROSCLEROSIS (2008)
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
Miles C. Miller et al.
BRAIN RESEARCH (2008)
Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products
Jong Sun Chang et al.
CIRCULATION RESEARCH (2008)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Role of advanced glycation end products in diabetic neuropathy
Kazuhiro Sugimoto et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE(-/-) mice
Evis Harja et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
RAGE signaling sustains inflammation and promotes tumor development
Christoffer Gebhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
RAGE ligation affects T cell activation and controls T cell differentiation
Yali Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of the receptor for advanced glycation end-products in lung fibrosis
Mei He et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes
Sho-ichi Yamagishi et al.
CURRENT DRUG TARGETS (2007)
Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products
Yuichi Kaji et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
RAGE control of diabetic nephropathy in a mouse model -: Effects of RAGE gene disruption and administration of low-molecular weight heparin
Khin-Mar Myint et al.
DIABETES (2006)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
The RAGE axis in early diabetic retinopathy
GR Barile et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma
B Bartling et al.
CARCINOGENESIS (2005)
Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren's syndrome: a preliminary study
J Katz et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Receptor for advanced glycation end-products is a marker of type I lung alveolar cells
M Shirasawa et al.
GENES TO CELLS (2004)
Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products
YL Chen et al.
JOURNAL OF IMMUNOLOGY (2004)
Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study
AP Burke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
A Flyvbjerg et al.
DIABETES (2004)
RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice
O Arancio et al.
EMBO JOURNAL (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Central role of RAGE-dependent neointimal expansion in arterial restenosis
T Sakaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
SM Hofmann et al.
DIABETES (2002)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism
LF Lue et al.
EXPERIMENTAL NEUROLOGY (2001)
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
MT Goova et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration
N Nagy et al.
LABORATORY INVESTIGATION (2001)
Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress
SF Yan et al.
NATURE MEDICINE (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
